Clinical Trials
4
Active:1
Completed:1
Trial Phases
4 Phases
Phase 1:1
Phase 2:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (25.0%)Phase 1
1 (25.0%)Phase 2
1 (25.0%)Phase 4
1 (25.0%)Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib
Not Applicable
Not yet recruiting
- Conditions
- Melanoma BRAF V600E/K Mutated
- Interventions
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-29
- Lead Sponsor
- SRH Wald-Klinikum Gera GmbH
- Target Recruit Count
- 101
- Registration Number
- NCT07092410
Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- SRH Wald-Klinikum Gera GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT03035188
- Locations
- 🇩🇪
SRH Wald-Klinikum Gera GmbH, Gera, Thuringia, Germany
🇩🇪Klinikum Augsburg Süd, Augsburg, Germany
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
News
No news found